Sci Adv
. 2021 Jun 16;7(25):eabf8577.
doi: 10.1126/sciadv.abf8577. Print 2021 Jun.
Targeting highly pathogenic coronavirus-induced apoptosis reduces viral pathogenesis and disease severity
Hin Chu 1 2 3 , Huiping Shuai 1 2 , Yuxin Hou 2 , Xi Zhang 2 , Lei Wen 2 , Xiner Huang 2 , Bingjie Hu 2 , Dong Yang 2 , Yixin Wang 2 , Chaemin Yoon 2 , Bosco Ho-Yin Wong 2 , Cun Li 2 , Xiaoyu Zhao 2 , Vincent Kwok-Man Poon 2 , Jian-Piao Cai 2 , Kenneth Kak-Yuen Wong 4 , Man-Lung Yeung 1 2 3 , Jie Zhou 1 2 3 , Rex Kwok-Him Au-Yeung 5 , Shuofeng Yuan 1 2 3 , Dong-Yan Jin 6 , Kin-Hang Kok 1 2 , Stanley Perlman 7 , Jasper Fuk-Woo Chan 8 2 3 9 10 , Kwok-Yung Yuen 8 2 3 9 10
Affiliations
- PMID: 34134991
- DOI: 10.1126/sciadv.abf8577
Abstract
Infection by highly pathogenic coronaviruses results in substantial apoptosis. However, the physiological relevance of apoptosis in the pathogenesis of coronavirus infections is unknown. Here, with a combination of in vitro, ex vivo, and in vivo models, we demonstrated that protein kinase R-like endoplasmic reticulum kinase (PERK) signaling mediated the proapoptotic signals in Middle East respiratory syndrome coronavirus (MERS-CoV) infection, which converged in the intrinsic apoptosis pathway. Inhibiting PERK signaling or intrinsic apoptosis both alleviated MERS pathogenesis in vivo. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-CoV induced apoptosis through distinct mechanisms but inhibition of intrinsic apoptosis similarly limited SARS-CoV-2- and SARS-CoV-induced apoptosis in vitro and markedly ameliorated the lung damage of SARS-CoV-2-inoculated human angiotensin-converting enzyme 2 (hACE2) mice. Collectively, our study provides the first evidence that virus-induced apoptosis is an important disease determinant of highly pathogenic coronaviruses and demonstrates that this process can be targeted to attenuate disease severity.